Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: 2011

View all 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Archive
 

Recommendations - 2011

Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
Source: MMWR, May 27, 2011; 60(20):661-3
HTML  |  PDF
Update on Japanese Encephalitis Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years -- United States, 2011
Source: MMWR, February 11, 2011; 60(5):1-4
HTML  |  PDF
Recommended Adult Immunization Schedule --- United States, 2011
Source: MMWR, February 4, 2011; 60(04):1-4
HTML  |  PDF
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
This page was reviewed on January 17, 2012
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.